Buy-and-build strategies, a mainstay of the PE toolkit in developed markets, are gaining exposure in emerging Asia’s healthcare sector. Proving a viable exit path will be the key to widespread adoption
Over the past three years, Asia Healthcare Holdings (AHH) has been quietly devising a new playbook for PE participation in India’s healthcare sector. Starting with the acquisition of Cancer Treatment...
Abu Dhabi sovereign wealth fund Mubadala has agreed to invest INR90.9 billion ($1.2 billion) in Jio Platforms, the holding company for various internet and telecom assets owned by Indian oil-to-retail conglomerate Reliance Industries.
Bessemer Venture Partners has led an INR1.5 billion ($20 million) Series B round for teleconsultation health platform DocsApp.
Everest Medicines, a China-based biopharmaceutical company, has raised $310 million in Series C funding across two tranches.
Bespin Global, a Seoul and Beijing-based cloud management services provider, has raised RMB530 million ($74.6 million) in a Series C round from SK Telecom and existing investor DY Holdings.